Evidence map›Paper›PMID 37915895›Full record

ArticleClinical kidney journal2023

Prevalence of pericardial effusion in autosomal dominant polycystic kidney disease.

Johanna Sophia Jost, Till Frederik Kaireit, Bernd Auber, Johannes Beller, Kai Martin Schmidt-Ott, Roland Schmitt, Vera Christine Wulfmeyer

Abstract read
In one paragraph

Article in Clinical kidney journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Cardiovascular Complications in ADPKD.Kidney international reports · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Johanna Sophia JostDepartment of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.
Till Frederik KaireitDepartment of Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany.
Bernd AuberDepartment of Human Genetics, Hannover Medical School, Hannover, Germany.ORCID https://orcid.org/0000-0003-1880-291X
Johannes BellerMedical Sociology Unit, Hannover Medical School, Hannover, Germany.
Kai Martin Schmidt-OttDepartment of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.
Roland SchmittDepartment of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.
Vera Christine WulfmeyerDepartment of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Autosomal dominant polycystic kidney disease (ADPKD) has numerous extrarenal manifestations. Pericardial effusion (PE) may be an underrecognized complication with a reported prevalence of up to 35%. Our study is the first to systematically evaluate the prevalence of PE and associated risk factors in an ADPKD cohort outside the USA. Methods: Clinically stable ADPKD patients from a specialized outpatient clinic were evaluated retrospectively. Magnetic resonance tomography and computed tomography scans were analysed regarding the presence of PE (≥4 mm). Imaging results were linked to clinical characteristics. Results: Of 286 ADPKD patients, 208 had computed tomography or magnetic resonance imaging suitable for evaluation of PE. In this group we detected PE in 17 patients (8.2%). The overall prevalence of PE was 6.3%, with more females being affected (prevalence of PE was 7.8% in females and 3.8% in males). The PE mean size was 6.8 ± 3.3 mm. The prevalence of autoimmune diseases was higher in the patients with PE (11.8% versus 2.1%, Conclusions: PE prevalence in our cohort was lower than previously reported and showed a clear female preponderance. Our data suggest that patients with PEs >10 mm deserve further attention, as they may have additional non-ADPKD-related pathologies.

Indexed as

autosomal dominant polycystic kidney diseaseextrarenal manifestationfemale preponderancepericardial effusionprevalence

Identifiers

PMID37915895
PMCPMC10616529

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.